Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia-MedSci.cn

Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia

Wang, Y; Wang, DY; Wang, Y; Yang, HT; Wang, G; Wu, SS

Wu, SS (通讯作者)，First Hosp Jilin Univ, Dept Pediat Hematol, Changchun, Peoples R China.;Wang, G; Wu, SS (通讯作者)，Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Peoples R China.

NEOPLASMA, 2023; 70 (2): 287

Abstract

The 5-year overall survival rate of acute myeloid leukemia (AML) is less than 30%. Improving clinical outcomes is still a clinical challenge for AML t......

Full Text Link